Matti Aapro
Researcher Next ID · RN-034195
Researcher · Biochemistry, Genetics and Molecular Biology
Genolier, Switzerland
- Works count
- 855
- Citation count
- 43,952
- H-index
- 104
- i10-index
- 368
Research interests
Publications
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.09.010
Bone health in cancer: ESMO Clinical Practice Guidelines
Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.07.019
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
European Journal of Cancer · 2019 · https://doi.org/10.1016/j.ejca.2019.04.031
Integration of oncology and palliative care: a Lancet Oncology Commission
The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30415-7
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy192
European Society for Medical Oncology (ESMO) position paper on supportive and palliative care
Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx757
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Annals of Oncology · 2017 · https://doi.org/10.1093/annonc/mdx758
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
Journal of bone oncology · 2017 · https://doi.org/10.1016/j.jbo.2017.03.001
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Annals of Oncology · 2016 · 10.1093/annonc/mdw544
3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)
The Breast · 2016 · https://doi.org/10.1016/j.breast.2016.10.001
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
Annals of Oncology · 2016 · 10.1093/annonc/mdw325
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
Annals of Oncology · 2016 · 10.1093/annonc/mdw270
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting
New England Journal of Medicine · 2016 · 10.1056/nejmra1515442
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
Annals of Oncology · 2015 · https://doi.org/10.1093/annonc/mdv617
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Annals of Oncology · 2014 · https://doi.org/10.1093/annonc/mdu385
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology
The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70018-x
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
The Breast · 2014 · https://doi.org/10.1016/j.breast.2014.08.009
Bone health in cancer patients: ESMO Clinical Practice Guidelines
Annals of Oncology · 2014 · 10.1093/annonc/mdu103
Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013
Annals of Oncology · 2014 · 10.1093/annonc/mdu253
1st International consensus guidelines for advanced breast cancer (ABC 1)
The Breast · 2012 · https://doi.org/10.1016/j.breast.2012.03.003
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
The Lancet Oncology · 2012 · 10.1016/s1470-2045(11)70383-7
The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)
Annals of Oncology · 2012 · https://doi.org/10.1093/annonc/mds021
Delivering affordable cancer care in high-income countries
The Lancet Oncology · 2011 · 10.1016/s1470-2045(11)70141-3
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
European Journal of Cancer · 2010 · https://doi.org/10.1016/j.ejca.2010.10.013
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
Annals of Oncology · 2010 · 10.1093/annonc/mdq194
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
Annals of Oncology · 2007 · 10.1093/annonc/mdm442
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update
European Journal of Cancer · 2006 · https://doi.org/10.1016/j.ejca.2006.10.014
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
European Journal of Cancer · 2006 · https://doi.org/10.1016/j.ejca.2006.05.002
Use of comprehensive geriatric assessment in older cancer patients:
Critical Reviews in Oncology/Hematology · 2005 · 10.1016/j.critrevonc.2005.06.003
Cancer-Related Anemia: Pathogenesis, Prevalence and Treatment
Oncology · 2005 · https://doi.org/10.1159/000083128
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer
European Journal of Cancer · 2004 · https://doi.org/10.1016/j.ejca.2004.07.015
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron
Annals of Oncology · 2003 · 10.1093/annonc/mdg417
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Annals of Oncology · 2003 · https://doi.org/10.1093/annonc/mdg112
Comprehensive Geriatric Assessment Adds Information to Eastern Cooperative Oncology Group Performance Status in Elderly Cancer Patients: An Italian Group for Geriatric Oncology Study
Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.20.2.494
Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy
Journal of Clinical Oncology · 1999 · 10.1200/jco.1999.17.5.1413
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
Journal of Clinical Oncology · 1997 · 10.1200/jco.1997.15.1.103
Cancer in the elderly: why so badly treated?
The Lancet · 1990 · 10.1016/0140-6736(90)91075-l
Current projects
No projects listed.